Emerging therapeutic agents for lung cancer

por Dholaria, Bhagirathbhai, Hammond, William, Shreders, Amanda, Lou, Yanyan
Publicado 2016

Targeted therapy in advanced non-small cell lung cancer: current advances and future trends

por Majeed, Umair, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Publicado 2021

ZNF277 regulates ovarian cancer cell proliferation and invasion through inhibition of PTEN

por Liu, Zhengling, Xu, Zonglan, Tian, Yonghui, Yan, Hua, Lou, Yanyan
Publicado 2019

Patients with high-grade alectinib-induced skin rash: How do we desensitize these patients? A case report and review of literature

por Seegobin, Karan, Majeed, Umair, Lou, Yanyan, Zhao, Yujie, Manochakian, Rami
Publicado 2020

Next generation of immune checkpoint inhibitors and beyond

por Marin-Acevedo, Julian A., Kimbrough, ErinMarie O., Lou, Yanyan
Publicado 2021

Trends in participant race and sex reporting in lung cancer phase III clinical trials

por Aslam, Faaiq N., Manochakian, Rami, Lou, Yanyan, Colon‐Otero, Gerardo, Sher, Taimur
Publicado 2023

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer

por Wiest, Nathaniel, Majeed, Umair, Seegobin, Karan, Zhao, Yujie, Lou, Yanyan, Manochakian, Rami
Publicado 2021

Immunotherapy in Non-Small Cell Lung Cancer With Actionable Mutations Other Than EGFR

por Seegobin, Karan, Majeed, Umair, Wiest, Nathaniel, Manochakian, Rami, Lou, Yanyan, Zhao, Yujie
Publicado 2021

Preparation of Cross-Linked Graphene Oxide on Polyethersulfone Membrane for Pharmaceuticals and Personal Care Products Removal

por Lou, Yanyan, Tan, Fibor J., Zeng, Rong, Wang, Mengen, Li, Pan, Xia, Shengji
Publicado 2020

First Report of Management of Sequential Small Cell Transformation and ALK I1171T Mutation as Resistance Mechanisms in a Patient With ALK-EML4 Fused Non–Small Cell Lung Adenocarcin...

por Majeed, Umair, Li, Shenduo, Seegobin, Karan, Nassar, Aziza, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Publicado 2023

Cancer immunotherapy beyond immune checkpoint inhibitors

por Marin-Acevedo, Julian A., Soyano, Aixa E., Dholaria, Bhagirathbhai, Knutson, Keith L., Lou, Yanyan
Publicado 2018

Immunotherapies targeting stimulatory pathways and beyond

por Marin-Acevedo, Julian A., Kimbrough, ErinMarie O., Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Publicado 2021

Editorial: Immunotherapy for NSCLC with oncogenic driver variants

por Du, Yijia, Chu, Qian, Lou, Yanyan, He, Yong, Hu, Hongbo, Hu, Qipeng, Huang, Meijuan
Publicado 2022

Emerging Targeted Therapies in Advanced Non-Small-Cell Lung Cancer

por Li, Shenduo, de Camargo Correia, Guilherme Sacchi, Wang, Jing, Manochakian, Rami, Zhao, Yujie, Lou, Yanyan
Publicado 2023

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

por Huang, Min, Lou, Yanyan, Pellissier, James, Burke, Thomas, Liu, Frank Xiaoqing, Xu, Ruifeng, Velcheti, Vamsidhar
Publicado 2017

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine de...

por Cai, Weijing, Zhou, Dapeng, Wu, Weibo, Tan, Wen Ling, Wang, Jiaqian, Zhou, Caicun, Lou, Yanyan
Publicado 2018

Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

por Pan, Deng, Zhou, Dapeng, Cai, Weijing, Wu, Weibo, Tan, Wen Ling, Zhou, Caicun, Lou, Yanyan
Publicado 2019

Next generation of immune checkpoint therapy in cancer: new developments and challenges

por Marin-Acevedo, Julian A., Dholaria, Bhagirathbhai, Soyano, Aixa E., Knutson, Keith L., Chumsri, Saranya, Lou, Yanyan
Publicado 2018

BRAF p.V600E associated poly-neoplastic syndrome

por Alhaj Moustafa, Muhamad, Jiang, Liuyan, Kuhlman, Justin J, Jones, Jeremy, Lou, Yanyan, Sokumbi, Olayemi, Tun, Han W
Publicado 2021

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

por Pal, Krishnendu, Hussain, Tabish, Xie, Hao, Li, Shenduo, Yang, Ping, Mansfield, Aaron, Lou, Yanyan, Chowdhury, Shantanu, Mukhopadhyay, Debabrata
Publicado 2022